{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:54:02Z","timestamp":1770065642772,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T00:00:00Z","timestamp":1713657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.conctc.2024.101301","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T03:29:27Z","timestamp":1714102167000},"page":"101301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Levelling the playing field through the London Network of the UK clinical trials accelerator platform"],"prefix":"10.1016","volume":"39","author":[{"given":"Jessie","family":"Matthews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Dobra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-5885","authenticated-orcid":false,"given":"Gemma","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Bossley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Brendell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossa","family":"Brugha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6946-0993","authenticated-orcid":false,"given":"Shenna","family":"Cadiente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4234-793X","authenticated-orcid":false,"given":"Loren","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-2728","authenticated-orcid":false,"given":"Gwyneth","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-3286","authenticated-orcid":false,"given":"Charlotte","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2323-442X","authenticated-orcid":false,"given":"Stuart","family":"Elborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-3611","authenticated-orcid":false,"given":"Dominic","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jess","family":"Longmate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-5295","authenticated-orcid":false,"given":"Caroline","family":"Pao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Round","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-4780","authenticated-orcid":false,"given":"Nicholas","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-8339","authenticated-orcid":false,"given":"Michael","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-1199","authenticated-orcid":false,"given":"Jane C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2024.101301_bib1","series-title":"UK Cystic Fibrosis Registry 2022 Annual Data Report","author":"Fibrosis Trust","year":"2023"},{"issue":"19","key":"10.1016\/j.conctc.2024.101301_bib2","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10212","key":"10.1016\/j.conctc.2024.101301_bib3","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.conctc.2024.101301_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","article-title":"ARRIVAL study group. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study","volume":"6","author":"Rosenfeld","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.conctc.2024.101301_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071527","article-title":"Real-world outcomes of ivacaftor treatment in people with cystic fibrosis: a systematic review","volume":"10","author":"Duckers","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.conctc.2024.101301_bib6","unstructured":"Introduction | European Cystic Fibrosis Society (ECFS) [Internet]. [cited 2018 Mar 14]. Available from: https:\/\/www.ecfs.eu\/ctn.."},{"key":"10.1016\/j.conctc.2024.101301_bib8","unstructured":"ECFS-CTN Annual reports | European Cystic Fibrosis Society (ECFS) [Internet]. [cited 2024 Mar 18]. Available from: https:\/\/www.ecfs.eu\/ecfs-ctn-annual-reports.."},{"key":"10.1016\/j.conctc.2024.101301_bib9","unstructured":"General health by region, January to December 2014 - Office for National Statistics [Internet]. [cited 2022 Jun 16]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthandlifeexpectancies\/adhocs\/004863generalhealthbyregionjanuarytodecember2014.."},{"key":"10.1016\/j.conctc.2024.101301_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g3231","article-title":"The impact of NHS resource allocation policy on health inequalities in England 2001-11: longitudinal ecological study","volume":"348","author":"Barr","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2024.101301_bib11","unstructured":"Involve patients | NIHR [Internet]. [cited 2020 Aug 29]. Available from: https:\/\/www.nihr.ac.uk\/health-and-care-professionals\/engagement-and-participation-in-research\/involve-patients.htm.."},{"key":"10.1016\/j.conctc.2024.101301_bib12","unstructured":"Trials Tracker [Internet]. [cited 2022 Jun 16]. Available from: https:\/\/www.cysticfibrosis.org.uk\/get-involved\/clinical-trials\/trialstracker.."},{"issue":"9","key":"10.1016\/j.conctc.2024.101301_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.conctc.2024.101301_bib14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/thoraxjnl-2013-204023","article-title":"London Cystic Fibrosis Collaboration (LCFC). Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants","volume":"69","author":"Nguyen","year":"2014","journal-title":"Thorax"},{"issue":"9297","key":"10.1016\/j.conctc.2024.101301_bib15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0140-6736(01)06970-7","article-title":"Airway function in infants newly diagnosed with cystic fibrosis","volume":"358","author":"Ranganathan","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.conctc.2024.101301_bib16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcf.2021.03.027","article-title":"Optimising equity of access: how should we allocate slots to the most competitive trials in Cystic Fibrosis (CF)?","volume":"20","author":"Dobra","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.conctc.2024.101301_bib17","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jcf.2019.04.008","article-title":"Who and why; sharing our experiences of developing a standard operating procedure (SOP) to allocate screening slots for highly competitive cystic fibrosis trials","volume":"18","author":"Dobra","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"7","key":"10.1016\/j.conctc.2024.101301_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MPA.0b013e3181da91dd","article-title":"Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials","volume":"39","author":"El-Rayes","year":"2010","journal-title":"Pancreas"},{"issue":"11","key":"10.1016\/j.conctc.2024.101301_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurjhf\/hfp133","article-title":"Is taking part in clinical trials good for your health? A cohort study","volume":"11","author":"Clark","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.conctc.2024.101301_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/hex.12935","article-title":"How patient and community involvement in diabetes research influences health outcomes: a realist review","volume":"22","author":"Harris","year":"2019","journal-title":"Health Expect."},{"key":"10.1016\/j.conctc.2024.101301_bib21","article-title":"Exploring Impact: public involvement in NHS, public health and social care research","author":"Staley","year":"2009","journal-title":"INVOLVE, Eastleigh"},{"issue":"4","key":"10.1016\/j.conctc.2024.101301_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s40271-014-0065-0","article-title":"A systematic review of the impact of patient and public involvement on service users, researchers and communities","volume":"7","author":"Brett","year":"2014","journal-title":"Patient"},{"issue":"6","key":"10.1016\/j.conctc.2024.101301_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jcf.2021.03.021","article-title":"Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: a Delphi study","volume":"20","author":"Dobra","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.conctc.2024.101301_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcf.2023.04.024","article-title":"A discrete choice experiment to quantify the influence of trial features on the decision to participate in cystic fibrosis trials","volume":"23","author":"Dobra","year":"2023","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.conctc.2024.101301_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jacbts.2021.01.011","article-title":"Decentralized clinical trials: the future of medical product development?","volume":"6","author":"Van Norman","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.conctc.2024.101301_bib26","first-page":"23","article-title":"Telemedicine and cystic fibrosis: do we still need face-to-face clinics?","volume":"42","author":"Dixon","year":"2022","journal-title":"Paediatr. Respir. Rev."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T22:58:59Z","timestamp":1720825139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865424000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":25,"alternative-id":["S2451865424000486"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101301","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levelling the playing field through the London Network of the UK clinical trials accelerator platform","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101301"}}